Macro to Micro: Performance of Investments in Microfinance in the Current Financ...

Print
 
Apr 2009
New York, United States, April, 10 2009 - Topics covered during this event include: 1. MFIs in the Trenches, and Specific Regional Differences 2. Investors as they React to the Sector’s Challenges. Thursday, May 7, 2009, New York.

The on-going financial market crisis is hitting microfinance institutions and their investors. However, various country and/or market characteristics combined with individual institution policies are resulting in differing consequences. Come hear from the experts running these operations as they discuss their insights on what are driving these differences and how they are dealing with the challenges. Then hear how investors (public and private) are assessing the same challenges in their investment decisions. This will be a great evening with a lively and broad ranging panel examining the story of how a sector whose chief purpose is to supply small loans to those without collateral or access to traditional financial services is at once maturing and reshaping itself during this time of turmoil.

Panelists

Roland Dominicé, Executive Director, Symbiotics – an investment advisor, assists microfinance investment vehicles (MIVs) with their buy side processes. Prior to this position, Mr. Dominicé was in charge of client relationship and business development for Symbiotics since co-founding the company in 2004.

Ann Miles, Managing Director, BlueOrchard Finance, S.A. – manages the US operations, BlueOrchard Finance USA, Inc. Ann has over 20 years experience in the financial services industry and microfinance. She worked with the BlueOrchard team on the first rated CLO for microfinance. BlueOrchard now manages approximately $800 million in assets for several institutional and high net worth clients and through its debt funds, has made loans to more than 145 microfinance institutions in 40 countries.

Camilla Nestor, Director, Grameen Foundation – Camilla manages the Capital Management & Advisory Center (CMAC). She has 13-years of experience in microfinance and commercial banking including origination and execution of credit-enhanced debt financings for emerging market firms as well as working with microfinance institutions in a variety of start-up, and capital raising situations.

Susanna K. Tisa, Managing Director, FINCA International – directs FINCA International’s Capital Markets funding and investor relations activities and advises FINCA on matters related to capital structure and risk management. She has over 25 years of experience in the financial services industry specializing in corporate finance, capital markets, and treasury.

Mitchell Strauss, Special Advisor SME Finance & Director of Credit Policy, Overseas Private Investment Corporation (OPIC) – is responsible for policy matters and origination of innovative financing structures designed specifically for SMEs in the developing world and advises on new financing structures for socially responsible segments in the business world. As a former banker, she has held various positions in finance and credit administration.

Moderated by Andrea M. Esposito, Managing Director, Standard & Poor’s, New York – Andrea is responsible for business development, and management of the America’s Microfinance projects and coordination of Global Microfinance initiatives.

Location:

McGraw-Hill Companies
1221 Avenue of the Americas (bet 48th & 49th Streets)
Rockefeller Center
New York

Thursday, May 7, 2009
5:30 – 6:30 pm
Registration & Networking
6:30 - 8:00 pm
Panel Discussion & Q&A

Registration Deadline:

May 5, 2009



 

Research Analysis Tools

The fund indexes, institution benchmarks and other market information displayed here are all Symbiotics designed analysis tools, created in-house by our analysts and experts. Symbiotics has one of the oldest track records in microfinance investment analysis dating back to the late 1990s; its indexes and benchmarks have been regularly used as markers by investors, asset managers, financial institutions and practitioners. These, as well as several other research products, are available through the Research Account. Click on the link below to find out more.

Learn More